Characterisation of a human cell-adapted porcine endogenous retrovirus PERV-A/C

Annals of Transplantation

Volumn 15, Issue 2, 2010, Pages 45-54

  Karlas, Alexander ^a   Irgang, Markus ^a   Votteler, Jörg ^a   Specke, Volker ^a   Özel, Mushin ^a   Kurth, Reinhard ^a   Denner, Joachim ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

Author keywords

Immunosuppression; PERV; Porcine endogenous retroviruses; Replication

Indexed keywords

ANIMAL CELL; ARTICLE; ENDOCYTOSIS; ENVELOPE GENE; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; LONG TERMINAL REPEAT; NONHUMAN; PORCINE ENDOGENOUS RETROVIRUS; RETROVIRUS; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY; VIRION; VIRUS INFECTIVITY; VIRUS REPLICATION; VIRUS TITRATION; XENOTRANSPLANTATION; ANIMAL; CELL LINE; CLASSIFICATION; ENDOGENOUS RETROVIRUS; GENETIC RECOMBINATION; GENETICS; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PAN TROGLODYTES; PATHOGENICITY; RHESUS MONKEY; RNA SPLICING; SEQUENCE HOMOLOGY; SPECIES DIFFERENCE; SWINE; ULTRASTRUCTURE; VIROLOGY; VIRUS CULTURE;

VIRUS DNA; VIRUS RNA;

ANIMALS; BASE SEQUENCE; CELL LINE; DNA, VIRAL; ENDOGENOUS RETROVIRUSES; HUMANS; MACACA MULATTA; MICROSCOPY, ELECTRON, SCANNING; MOLECULAR SEQUENCE DATA; PAN TROGLODYTES; RECOMBINATION, GENETIC; RNA SPLICING; RNA, VIRAL; SEQUENCE HOMOLOGY, NUCLEIC ACID; SPECIES SPECIFICITY; SWINE; TERMINAL REPEAT SEQUENCES; VIRUS CULTIVATION;

EID: 77954630631     PISSN: 14259524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Ericsson T, Oldmixon B, Blomberg J et al: Identification of novel porcine endogenous betaretrovirus sequences in miniature swine. J Virol, 2001; 75(6): 2765-70
2. Patience C, Takeuchi Y, Weiss R: Infection of human cells by an endogenous retrovirus of pigs. Nat Med, 1997; 3: 282-86
3. Patience C, Switzer W, Takeuchi Y et al: Multiple groups of novel retroviral genomes in pigs and related species. J Virol, 2001; 75: 2771-75
4. Le Tissier P, Stoye JP, Takeuchi Y et al: Two sets of human-tropic pig retrovirus. Nature, 1997; 389: 681-82
5. Martin U, Steinhoff G, Kiessig V et al: Expression of pig endogenous retrovirus by primary porcine endothelial cells and infection of human cells. Lancet, 1998; 352: 692-94
6. Tacke SJ, Specke V, Denner J: Differences in release and determination of subtype of porcine endogenous retroviruses (PERV) produced by stimulated normal pig blood cells. Intervirology, 2003; 46: 17-24
7. Wilson C, Wong S, Muller J et al: Type C retrovirus released from porcine primary peripheral blood mononuclear cells infects human cells. J Virol, 1998; 72: 3082-87
8. Martin U, Winkler M, Id M et al: Productive infection of primary human endothelial cells by pig endogenous retrovirus (PERV). Xenotransplantation, 2000; 7: 138-42
9. Specke V, Rubant S, Denner J: Productive infection of human primary cells and cell lines with porcine endogenous retroviruses. Virology, 2001; 285: 177-80
10. Denner J: Immunosuppression by retroviruses: implications for xenotransplantation. Ann NY Acad Sci, 1998; 862: 75-86
11. Tacke S, Kurth R, Denner J: Porcine endogenous retroviruses inhibit human immune cell function: risk for xenotransplantation? Virology, 2000; 268: 87-93
12. Takeuchi Y, Patience C, Magre S et al: Host range and interference studies of three classes of pig endogenous retrovirus. J Virol, 1998; 72: 9986-91
13. Denner J: Xenotransplantation: State of the art of biosafety. In: Jansen ES, Simon JW, (eds.), Xenotransplantation - ethic, economic, social, cultural and scientific background. Saarbrücken: VDM-Verlag; 2008; 7-78
14. Elliott RB, Escobar L, Garkavenko O et al: No evidence of infection with porcine endogenous retrovirus in recipients of encapsulated porcine islet xenografts. Cell Transplant, 2000; 9: 895-901
15. Garkavenko O, Croxson MC, Irgang M et al: Monitoring for presence of potentially xenotic viruses in recipients of pig islet xenotransplantation. J Clin Microbiol, 2004; 42(11): 5353-56
16. Paradis K, Langford G, Long Z et al: Search for cross species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. The XEN 111 Study Group. Science, 1999; 285: 1236-41
17. Tacke S, Bodusch K, Berg A, Denner J: Sensitive and specific immunological detection methods for porcine endogenous retroviruses applicable to experimental and clinical xenotransplantation. Xenotransplantation, 2001; 8: 125-35
18. Denner J: Porcine endogenous retroviruses (PERVs) and xenotransplantation: screening for transmission in several clinical trials and in experimental models using non-human primates. Ann Transplant, 2003; 8: 39-48
19. Specke V, Tacke S, Boller K et al: Porcine endogenous retroviruses: in vitro host range and attempts to establish small animal models. J Gen Virol, 2001; 82: 837-44
20. Specke V, Plesker R, Coulibaly C et al: Productive infection of a mink cell line with porcine endogenous retroviruses (PERVs) and lack of transmission to minks in vivo. Arch Virol, 2002; 147: 305-19
21. Specke V, Schuurman HJ, Plesker R et al: Virus safety in xenotransplantation: first exploratory in vivo studies in small laboratory animals and nonhuman primates. Transplant Immunology, 2002; 9: 281-88
22. Specke V, Plesker R, Wood J et al: No in vivo infection of triple immunosuppressed non-human primates after inoculation with high titers of porcine endogenous retroviruses (PERVs). Xenotransplantation, 2009; 16: 34-44
23. Argaw T, Colon-Moran W, Wilson CA: Limited infection without evidence of replication by porcine endogenous retrovirus in guinea pigs. J Gen Virol, 2004; 85(1): 15-19
24. Bartosch B, Stefanidis D, Myers R et al: Evidence and consequence of porcine endogenous retrovirus recombination. J Virol, 2004; 78: 13880-90
25. Denner J: Is porcine endogenous retrovirus (PERV) transmission still relevant? Transplant Proc, 2008; 40(2): 587-89
26. Dieckhoff B, Puhlmann J, Büscher K et al: Expression of porcine endogenous retroviruses (PERVs) in melanomas of Munich miniature swine (MMS) Troll Vet Microbiol, 2007; 123: 53-68
27. Martin SI, Wilkinson R, Fishman JA: Genomic presence of recombinant porcine endogenous retrovirus in transmitting miniature swine. J Virol, 2006; 3: 91-96
28. Wood JC, Quinn G, Suling KM et al: Identification of exogenous forms of human-tropic porcine endogenous retrovirus in miniature swine. J Virol, 2000; 78: 2494-501
29. Denner J, Specke V, Thiesen U et al: Genetic alterations of the long terminal repeat of an ecotropic porcine endogenous retrovirus (PERV) during passage in human cells. Virology, 2003; 314: 125-33
30. Wilson C, Wong S, VanBrocklin M, Federspiel M: Extended analysis of the in vitro tropism of porcine endogenous retrovirus. J Virol, 2000; 74: 49-56
31. Scheef G, Fischer N, Krach U, Tönjes R: The number of a U3 repeat box acting as an enhancer in long terminal repeats of polytropic replication-competent porcine endogenous retroviruses dynamically fluctuates during serial virus passages in human cells. J Virol, 2001; 75: 6933-40
32. Harrison I, Takeuchi Y, Bartosch B, Stoye JP: Determinants of high titer in recombinant porcine endogenous retroviruses. J Virol, 2004; 78: 13871-79
33. Wilson CA: Porcine endogenous retroviruses and xenotransplantation. Cell Mol Life Sci, 2008; 65(21): 3399-412
34. Ozel M, Pauli G, Gelderblom HR: The organization of the envelope projections on the surface of HIV. Arch Virol, 1988; 100: 255-66
35. Metzner C, Salmons B, Günzburg WH, Dangerfield JA: Rafts, anchors and viruses a role for glycosylphosphatidylinositol anchored proteins in the modification of enveloped viruses and viral vectors. Virology, 2008; 382(2): 125-31
36. Wang W, Fu YJ, Zu YG et al: Lipid rafts play an important role in the vesicular stomatitis virus life cycle. Arch. Virol, 2009; 154(4): 595-600
37. Denner J: Recombinant porcine endogenous retroviruses (PERV-A/C): A new risk for xenotrans-plantation? Arch Virol, 2008; 153: 1421-26
38. Wood A, Webb BL, Bartosch B et al: Porcine endogenous retroviruses PERV A and A/C recombinant are insensitive to a range of divergent mammalian TRIM5alpha proteins including human TRIM5alpha. J Gen Virol, 2009; 90: 702-9
39. Denner J, Schuurman H, Patience C: The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes - Chapter 5: Strategies to prevent transmission of porcine endogenous retroviruses Xenotransplantation, 2009; 16: 239-48
40. Dieckhoff B, Kessler B, Jobst D et al: Distribution and expression of porcine endogenous retroviruses (PERV) in multi-transgenic pigs generated for xenotransplantation. Xenotransplantation, 2009; 16: 64-73
41. Ericsson TA, Takeuchi Y, Templin C et al: Identification of receptors for pig endogenous retrovirus. PNAS, 2003; 100: 6759-64
42. Ritzhaupt A, van der Laan LJW, Salomon DR, Wilson CA: Porcine endogenous retrovirus infects but does not replicate in nonhuman primate cells and cell lines. J Virol, 2002; 76: 11312-20
43. Blusch JH, Patience C, Takeuchi Y et al: Infection of nonhuman primate cells by pig endogenous retrovirus. J Virol, 2000; 74: 7687-90
44. Garkavenko O, Dieckhoff B, Wynyard S et al: Absence of transmission of potentially xenotic viruses in a prospective pig to primate islet xenotransplantation study. J Med Virol, 2008; 80(11): 2046-52
45. Loss M, Arends H, Winkler M et al: Analysis of potential porcine endogenous retrovirus (PERV) transmission in a whole-organ xenotransplantation model without interfering microchimerism. Transpl Int, 2001; 14: 31-37
46. Goff SP: Retrovirus restriction factors. Mol Cell, 2004; 16(6): 849-59
47. Takeuchi H, Matano T: Host factors involved in resistance to retroviral infection. Microbiol Immunol, 2008; 52(6): 318-25
48. Mattiuzzo G, Takeuchi Y: PERV-A receptors in non-human primates: implication for their employment as an animal model for xenotransplantation. Xenotransplantation, 2009; 16(5): 383
49. Miyauchi K, Kim Y, Latinovic O et al: HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes. Cell, 2009; 137(3): 433-44
50. Fiebig U, Stephan O, Kurth R, Denner J: Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses (PERVs): basis for a vaccine for xenotransplantation? Virology, 2003; 307(2): 406-13